Global Hemoglobinopathies Market to Hit USD 20.50 Billion by 2034...

ha aggiunto un file Altre informazioni

2026-04-10 08:29:14 -

Global Hemoglobinopathies Market to Hit USD 20.50 Billion by 2034 Driven by Gene Therapy Breakthroughs and Rising Disease Prevalence

rising prevalence of genetic blood disorders such as sickle cell disease and beta-thalassemia, along with rapid progress in gene and cell-based therapies. The market is valued at USD 9.67 billion in 2025 and is expected to reach USD 20.50 billion by 2034, growing at a CAGR of 8.75% from 2026 to 2034. Increasing Global Disease Burden Accelerating Market Growth The growing number of patients...

0 Commenti 0 condivisioni 108 Views 0 Anteprima